Jingye Pharmaceutical, a trusted name in reliable, high-quality pharmaceutical production and healthcare solutions, officially unveiled its state-of-the-art Quality Control (QC) Center this week, marking a major milestone in the company’s commitment to safety, compliance, and industry-leading manufacturing standards.
The new facility is equipped with advanced testing equipment, automated analytical systems, and strict quality management protocols that meet both national and international pharmaceutical regulations, including strict GMP (Good Manufacturing Practice) guidelines. Designed to streamline product testing, purity verification, and safety inspections, the center strengthens Jingye Pharma’s end-to-end quality assurance across its full product portfolio, serving vital medical and pharmaceutical markets worldwide.
“Quality is the foundation of our business, and patient safety is our top priority,” said a senior spokesperson for Jingye Pharmaceutical. “This investment in our quality control capabilities reflects our dedication to delivering safe, effective, and consistent pharmaceutical products. We continue to uphold rigorous standards, optimize production processes, and support global healthcare demands with reliable, professional solutions.”
Alongside enhancing quality control, the company remains focused on technological innovation, customer-centric service, and long-term industry partnerships. Serving the pharmaceutical and medical sectors, Jingye Pharma combines diligent craftsmanship, reliable supply chains, and responsive after-sales support to build trust with partners and customers across the globe.
The opening of the new QC Center aligns with the company’s long-term growth strategy, reinforcing its position as a responsible and competitive player in the pharmaceutical industry. The company will continue to invest in operational excellence, sustainable practices, and product development to better serve global healthcare needs.
